About Morquio Syndrome
Morquio syndrome, also known as mucopolysaccharidosis IV or MPS IV, is a rare metabolic condition that affects a person's metabolism. It is a form of mucopolysaccharidoses (MPS), which are conditions that disrupt the enzymes responsible for breaking down long chains of sugars in the body. Specifically, in Morquio A syndrome, the body does not produce enough of certain enzymes needed to break down glycosaminoglycans, a type of sugar. As a result, these large sugar molecules build up to toxic levels in the body, leading to various problems in the bones, arteries, eyes, joints, ears, skin, and teeth.
There are two types of Morquio syndrome that have similar symptoms, but have different genetic causes:
- Morquio syndrome Type A: There is a deficiency in the N-acetyl-galactosamine-6-sulfatase (GALNS) enzyme. Morquio A usually has more severe symptoms than Morquio B. The majority of cases of Morquio syndrome in the U.S. are Type A.
- Morquio syndrome Type B: There is a deficiency of beta-galactosidase (GLB1) enzyme. Morquio B is considered a milder form of Morquio syndrome.
There currently is no cure for Morquio syndrome. Treatment focuses on managing the symptoms of the syndrome. There is an enzyme replacement therapy available for Morquio A.
Morquio syndrome is caused by a variation in the genes responsible for creating enzymes. The gene variant is inherited. Morquio syndrome is an autosomal recessive condition. This means that a person must receive a copy of the gene variation from both their parents to have the condition. If both parents possess the gene alteration, their child will have a 25% chance of developing Morquio syndrome.
The specific enzyme that a person is deficient in will depend on genetic variation. Morquio Type A (MPS IVA) occurs due to a variation in the GALNS gene, which affects the GALNS enzyme, while Morquio Type B (MPS IVB) occurs due to an alteration in the GLB1 gene, which impacts the beta-galactosidase enzyme.
Because Morquio syndrome is an inherited condition, there are no modifiable risk factors that a person can change or control.
Morquio syndrome is a metabolic condition that primarily affects the skeleton. The symptoms of Morquio syndrome can vary in severity and may develop over time. Morquio syndrome Type A is more progressive than Type B and is associated with more severe symptoms over time.
Symptoms of Morquio syndrome include:
- Short stature
- Knock knees: This is when a person's legs curve inwards, causing their feet to be apart when their knees touch.
- Problems with the ribs, chest, spine, hips, and wrists: These skeletal abnormalities can cause pain and limited mobility.
- Loose, flexible joints: Joints may have an increased range of motion and can be prone to dislocation.
- Restricted movement in certain joints: Some joints may have limited range of motion, making certain movements difficult.
- Underdevelopment of neck bones: This can result in a short neck.
As Morquio syndrome progresses or becomes more severe, individuals may experience additional symptoms such as:
- Vision loss
- Recurrent ear infections and hearing loss
- Frequent upper respiratory tract infections
- Pauses in breathing during sleep and poor sleep quality
- Excessive curvature of the spine (kyphoscoliosis)
- Flat feet
- Unusual development of long bones
- Hip dislocation
- Inflammation of the joints
- Breastbone (sternum) that protrudes outward
It's important to note that not all individuals with Morquio syndrome will experience all of these symptoms, and the severity of symptoms can vary from person to person.
To diagnose Morquio syndrome, healthcare professionals commonly perform the following examinations, tests, and procedures:
- Medical history: The healthcare professional will ask about the person's symptoms, family history, and any previous medical conditions or treatments.
- Physical examination: The healthcare professional will conduct a thorough physical examination to look for signs and symptoms of Morquio syndrome. This may include measuring height, assessing joint mobility, evaluating vision and hearing, and checking for other physical abnormalities.
- Skeletal X-rays: X-rays of the bones can help identify characteristic skeletal abnormalities associated with Morquio syndrome. These abnormalities often include abnormal bone development and spinal cord compression.
- Urine glycosaminoglycans (GAGs) analysis: GAGs are substances that can accumulate in the body in individuals with Morquio syndrome. A urine sample is collected and analyzed to measure the amount of GAGs, specifically keratan sulfate. High levels of keratan sulfate in the urine can indicate the presence of Morquio A syndrome.
- Genetic testing: Genetic testing involves analyzing a sample of tissue (such as blood or skin) to check for gene alterations associated with Morquio Syndrome. This test helps determine the specific type of Morquio syndrome a person has.
It's important to note that these diagnostic examinations, tests, and procedures should be performed by healthcare professionals experienced in diagnosing rare genetic disorders like Morquio syndrome.
The goals of treatment for Morquio syndrome are to manage symptoms, slow disease progression, and improve quality of life. While there is currently no cure for Morquio syndrome, there are several treatment options available to achieve these goals.
- Enzyme replacement therapy (ERT): ERT is a type of treatment that involves replacing the missing or deficient enzyme in the body. This is currently available for Morquio Type A. It is not available for Morquio Type B. For Morquio Type A, ERT is administered through intravenous (IV) infusions once a week. It works by helping to correct the enzyme deficiency and restore cell function in patients with Morquio A syndrome.
- Symptom management: Symptom management is an important aspect of treating Morquio syndrome. Healthcare professionals may offer various treatments to manage specific symptoms. For example:
- Surgery: Surgery may be recommended to prevent damage to the spinal cord or correct respiratory or vision problems.
- Physical rehabilitation: Physical rehabilitation, including physical therapy and exercises, can help improve mobility, strength, and flexibility.
- Psychological support: Emotional and psychological support can be provided to individuals with Morquio syndrome and their families to cope with the challenges associated with the condition.
- Learning optimization: For individuals who have difficulty seeing or hearing, learning optimization strategies can be implemented to support their educational needs.
- Mobility aids: Assistive devices such as wheelchairs or braces may be prescribed to enhance mobility and independence.
- Lifestyle behavior changes: Making certain lifestyle behavior changes can also contribute to managing Morquio syndrome effectively. These may include:
- Following a healthy diet: Consuming a balanced diet rich in nutrients can support overall health and well-being.
- Regular exercise: Engaging in regular physical activity within individual capabilities can help maintain muscle strength and flexibility.
- Avoiding activities that may worsen symptoms: Individuals with Morquio syndrome should avoid activities that put excessive strain on their joints or bones.
It's important to note that while enzyme replacement therapy with elosulfase alfa has shown significant advancements in managing Morquio A syndrome, continued research is needed to develop additional treatments. The treatment plan for each individual will be tailored based on their specific needs and goals.
In conclusion, treatment for Morquio syndrome aims to manage symptoms, slow disease progression, and improve quality of life. Enzyme replacement therapy for Morquio Type A, symptom management interventions such as surgery or physical rehabilitation, and lifestyle behavior changes all play important roles in achieving these treatment goals.
The natural progression of Morquio syndrome can vary from person to person, with Morquio Type A typically have a more rapid and severe progression than Morquio Type B. In severe cases, symptoms may appear before the age of one, while in milder cases, symptoms may not manifest until the person is in their 20s.
As Morquio syndrome progresses, individuals may experience a range of complications. Some of the most common complications include problems with the bones and joints, hearing and vision loss, problems with the heart valves, and difficulties with the lungs and breathing. Fatigue, sleep apnea, shortness of breath, blocked breathing tubes, and upper respiratory tract infections are also common with Morquio syndrome, especially Morquio Type A. Over time, these complications can lead to reduced quality of life.
In conclusion, Morquio syndrome is a progressive condition with a wide range of complications that can affect multiple systems in the body. While there is no cure for Morquio syndrome, enzyme replacement therapy has shown promise in slowing down disease progression and reducing complications for the more progressive Morquio Type A. It's important for individuals with Morquio syndrome to work closely with their healthcare team to determine the best treatment approach for their specific case.